Uteroplacental insufficiency and subsequent intrauterine growth retardation (IUGR) increase the risk of type 2 diabetes in humans and rats. Unsuppressed endogenous hepatic glucose production is a common component of the insulin resistance associated with type 2 diabetes. Peroxisome proliferator-activated receptor-␥ coactivator-1 (PGC-1) mediates hepatic glucose production by controlling mRNA levels of glucose-6-phosphatase (G-6-Pase), phosphoenolpyruvate carboxykinase (PEPCK), and fructose-1,6-bisphosphatase (FBPase). We therefore hypothesized that gene expression of PGC-1 would be increased in juvenile IUGR rat livers, and this increase would directly correlate with hepatic mRNA levels of PEPCK, G-6-Pase, and FBPase, but not glucokinase. We found that IUGR hepatic PGC-1 protein levels were increased to 230 ؎ 32% and 310 ؎ 47% of control values at d 0 and d 21 of life, respectively. Similarly, IUGR hepatic PGC-1 mRNA levels were significantly elevated at both ages. Concurrent with the increased PGC-1 gene expression, IUGR hepatic mRNA levels of G-6-Pase, PEPCK, and FBPase were also significantly increased, whereas glucokinase mRNA levels were significantly decreased. These data suggest that increased PGC-1 expression and subsequent hepatic glucose production contribute to the insulin resistance observed in the IUGR juvenile rat. (Endocrinology 143: 2486 -2490, 2002) 
B ARKER'S FETAL ORIGINS of Adult Disease Hypothesis
proposes that fetal adaptation to a deprived intrauterine milieu leads to permanent changes in cellular biology and systemic physiology. Intrauterine growth retardation (IUGR) predisposes affected newborns toward long-term morbidity from type 2 diabetes, as well as other components of syndrome X (1). Though both insulin deficiency and resistance contribute to the IUGR diabetic phenotype, lowponderal-index [weight/length (see Ref. 3)] IUGR individuals are often characterized by a preponderance of insulin resistance (2) . Uteroplacental insufficiency, a morbidity associated with many common complications of pregnancy (such as pregnancy induced hypertension) induces low ponderal index IUGR. In the rat, uteroplacental insufficiency results in juvenile IUGR animals whose glucose homeostasis is abnormal only when physiologically challenged on a pharmacological level (3) . By adulthood, adult IUGR rats develop overt diabetes that is characterized by fasting hyperglycemia and hyperinsulinemia (3, 4) .
An important component of the peripheral insulin resistance associated with type 2 diabetes is impaired suppression of endogenous hepatic glucose production, which is predominately the result of gluconeogenesis (5) .
The enzymes glucose-6-phosphatase (G-6-Pase), phosphoenolpyruvate carboxykinase (PEPCK), and fructose-1,6-bisphosphatase (FBPase) determine the rate of gluconeogenesis. It has been recently demonstrated that hepatic gene expression of these enzymes is controlled by peroxisome proliferator-activated receptor-␥ coactivator-1 (PGC-1) (6). IUGR persistently affects hepatic gene expression and function of several key metabolic enzymes throughout the life of the rat (7, 8) . We therefore hypothesized that hepatic PGC-1 gene expression would also be altered in the juvenile postnatal IUGR rat and that the change in gene expression would directly correlate with G-6-Pase, PEPCK, and FBPase mRNA levels, but not with glucokinase (GK) mRNA levels.
To prove this hypothesis, bilateral uterine artery ligation (IUGR) and sham surgery (controls or CON) were performed on d 19 of gestation (term, 21.5 d). Similar to the human, pups in this model experience decreased serum levels of glucose, insulin, branched chain amino acids, and oxygen (4, 8, 9) . Hepatic protein and mRNA levels of PGC-1 were measured in term CON and IUGR fetal rats (d 0) and 21-d-old rats (d 21); d 21 rats were investigated because peripheral insulin resistance without either fasting hyperglycemia or hyperinsulinemia characterizes these animals (3). Hepatic PGC-1 mRNA levels were measured using a standard RT-PCR technique control and real-time RT-PCR (10). Real-time RT-PCR was further used to measure hepatic mRNA levels of the gluconeogenic enzymes G-6-Pase, PEPCK, and FBPase, as well as GK, at d 21.
Abbreviations: CON, Sham surgery controls; CoxIV, cytochrome c oxidase subunit IV; FBPase, fructose-1,6-bisphosphatase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GK, glucokinase; G-6-Pase, glucose-6-phosphatase; IUGR, intrauterine growth retardation; mTFA, mitochondrial transcription factor A; NRF-1, nuclear respiratory factor-1; PEPCK, phosphoenolpyruvate carboxykinase; PGC-1, peroxisome proliferator-activated receptor-␥ coactivator-1.
Materials and Methods Animals
All procedures were approved by the UCLA Chancellor's Animal Research Committee. These surgical methods have been previous described (3, 4, 7, 8, 10 -13) . On d 19 of gestation, the maternal rats were anesthetized with ip xylazine (8 mg/kg) and ketamine (40 mg/kg), and both uterine arteries were ligated (IUGR) (n ϭ 8 litters). Sham surgery was performed on control animals, who underwent identical anesthetic and surgical procedures except for the uterine artery ligation (CON) (n ϭ 8 litters). Day-zero pups were delivered by cesarean section (n ϭ 4 litters, CON and IUGR, respectively). The remaining maternal rats were allowed to deliver spontaneously, and litters were randomly culled to 6; d 21 animals were separated from their dams for 4 h (to minimize individual hormonal variations associated with feeding), anesthetized, and killed (n ϭ 4, CON and IUGR, respectively). Liver was harvested and frozen in liquid nitrogen.
Western blotting
Protein was isolated, by centrifugation, after tissue homogenization in Laemmeli lysis buffer. A total of 100 g protein was separated on an SDS-PAGE gel along with molecular weight markers and subsequently transferred to nitrocellulose. The nitrocellulose was incubated in Blotto solution, and then with rabbit PGC-1 primary antibody (1:100) (Chemicon, Temecula, CA). The filters were then washed before incubation with secondary antirabbit antibody (1:1000 dilution). The filters were washed, and detection was performed using enhanced chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ). The products were quantified by densitometry after standardization for loading. Each blot was replicated three times.
RNA isolation
Total RNA was extracted from liver and quantified in triplicate using UV absorbance (14) . Gel electrophoresis confirmed the integrity of the samples. RNA was treated to deoxyribonuclease (Ambion, Inc., Austin, TX).
RT-PCR quantification using internal control and direct incorporation of radioactivity
To measure mRNA levels of PGC-1, a well-characterized method of RT-PCR was used that incorporates bovine retinal rhodopsin RNA as an internal control for both RT and amplification (4, 8, 10 -13) . cDNA was synthesized using random hexamers and SuperScript II RT (Life Technologies, Inc., Gaithersburg, MD) from 1.0 g hepatic RNA added to 0.01 g bovine retinal RNA. Reactions were replicated three times. Primer sequences are found in Table 1 . With each set of reverse transcription and amplification, serial dilutions were run to demonstrate that both PCR products were being produced in the exponential phase of amplification. Products were separated, and radioactivity was quantified by phosphorimaging. The relative abundance of target mRNA levels was quantified relative to that of the control rhodopsin band from the same reaction.
Verification of PGC-1 expression in the IUGR rat
Previous investigators have found that PGC-1 controls expression of genes affecting mitochondrial biogenesis and respiration (15) . Because the perinatal IUGR rat is characterized by increased hepatic mRNA levels of the mitochondrial gene reduced nicotinamide adenine dinucleotide ubiquinone-oxireductase 4 liter, we cross-referenced our findings by measuring mRNA levels of nuclear respiratory factor-1 (NRF-1), mitochondrial transcription factor A (mTFA), and cytochrome c oxidase subunit IV (CoxIV) in d 0 IUGR rats, using the technique described above (7).
Real-time RT-PCR
mRNA levels of PGC-1 were measured at d 0 and d 21, and mRNA levels of G-6-Pase, PEPCK, FBPase, and GK were measured at d 21. cDNA was synthesized from 0.5 g deoxyribonuclease-treated mRNA, as described above. Target (PGC-1, G-6-Pase, PEPCK, FBPase) primers and probes were designed using Primer Express Software (PE Applied Biosystems, Foster City, CA) ( Table 1) ; target probes were labeled with fluorescent reporter dye FAM. Before the performance of real-time PCR, all primer pairs are tested with serial Mg 2ϩ and primer concentrations to determine the optimal reaction conditions and to demonstrate the specificity of each primer pair. Reporter dye emission is detected by an automated sequence detector combined with ABI Prism 7700 Sequence Detection System software (PE Applied Biosystems). An algorithm normalizes the reporter signal (R n ) to a passive reference and multiples the sd of the background R n in the first cycles by a default factor of 10 to determine threshold C T . C T has a linear relation with the logarithm of the initial template copy number (16) . Real-time PCR quantification is then performed using the Taqman glyceraldehyde-3-phosphate dehydrogenase (GAPDH) controls. Before the use of GAPDH as a control, serial dilutions of cDNA are quantified to prove the validity of using GAPDH as an internal control. Relative quantification of PCR products are then based upon value differences between the target and GAPDH control using the comparative C T method (17) . Cycle parameters were 55 C ϫ 5 min, 95 C ϫ 10 min, and then 40 cycles of 95 C ϫ 15 sec360 C ϫ 60 sec. Each sample was analyzed in triplicate in assays performed on three occasions. To exclude the possibility that real-time PCR findings were a result of a nonspecific increase in mRNA levels, we also measured Bcl-2 mRNA levels in the d 21 samples.
Statistics
All data presented are expressed as mean percent of control Ϯ sem. For RT-PCR using the internal control, statistical analyses were performed using the nonparametric Wilcoxon matched-pair test. For realtime RT-PCR and Western blotting, statistical analyses were performed using ANOVA (Fisher's protected least-significance difference) and Student's unpaired t test. The Z-test was used to correlate PGC-1 mRNA levels from individual samples with G-6-Pase, PEPCK, and FBPase mRNA levels at d 21 of life, respectively. 
Results

Hepatic protein levels of PGC-1 at d 0 and d 21
Hepatic protein levels of PGC-1 at d 0 and d 21 were significantly increased to 230 Ϯ 32% and 310 Ϯ 47% of shamoperated CON values, respectively (P Ͻ 0.05) (Fig. 1) . In CON animals, d 21 hepatic protein levels were 189 Ϯ 13% of d 0 values, respectively (P Ͻ 0.05). No difference at either age was noted secondary to gender.
Hepatic mRNA levels of PGC-1 at d 0 and d 21
Using the traditional RT-PCR method, we found that d 0 and d 21 hepatic mRNA levels of PGC-1 were significantly increased in IUGR livers to 155 Ϯ 17% and 210 Ϯ 26% of control values, respectively ( Fig. 2A) (P Ͻ 0.05 for both ages). Similarly, hepatic mRNA levels of NRF-1 (180 Ϯ 16%), mTFA (229 Ϯ 31%), and CoxIV (164 Ϯ 19%) were significantly increased in IUGR animals, relative to sham-operated CON animals ( Fig. 2B ) (P Ͻ 0.05 for all three genes). No difference at either age was noted secondary to gender.
Hepatic mRNA levels of PGC-1, G-6-Pase, PEPCK, and FBPase
Using real-time RT-PCR, we found that hepatic d 0 and d 21 mRNA levels of PGC-1 were significantly increased to 186 Ϯ 13% and 233 Ϯ 17% of control values, respectively ( (Fig. 3) (P Ͻ 0.05 for all three genes). Moreover, when the extent of these increases was analyzed in comparison with the rise in PGC-1 mRNA levels on a sample-tosample basis, we found that the G-6-Pase (r ϭ 0.86; P Ͻ 0.05), PEPCK (r ϭ 0.79; P Ͻ 0.05), and FBPase (r ϭ 0.87; P Ͻ 0.01) mRNA levels correlated directly to PGC-1 mRNA levels. In contrast, mRNA levels of GK were significantly decreased to 46 Ϯ 7% of control values, and mRNA levels of Bcl-2 were not significantly altered in the IUGR animals (Fig. 3) .
Discussion
PGC-1 is a transcriptional coactivator of nuclear receptors that controls hepatic mRNA levels of the gluconeogenic enzymes G-6-Pase, PEPCK, and FBPase and subsequently affects hepatic gluconeogenesis (6) . PGC-1 mRNA levels are increased in liver-specific insulin-receptor knockout mice, which have been previously characterized by the failure of insulin to suppress hepatic glucose production and increased mRNA levels of gluconeogenic enzymes (6, 18) . Moreover, Wistar rats injected with adenovirus expressing PGC-1 demonstrate hyperglycemia and hyperinsulinemia, which are characteristic findings of increased hepatic glucose output in nondiabetic animals (6) . As a result, the significant correlation between PGC-1 mRNA levels and the mRNA levels of G-6-Pase, PEPCK, and FBPase suggests that PGC-1 is similarly contributing directly to the increased mRNA levels of these enzymes in this rat model of IUGR. Moreover, the finding of persistently increased PGC-1 expression in juvenile IUGR livers further suggests a molecular mechanism through which hepatic endogenous glucose production contributes to the peripheral insulin resistance described by Simmons et al. (3) .
Unsuppressed gluconeogenesis is often an early finding of NIDDM; and hormones such as insulin, glucagon, and glucocorticoids affect expression of the gluconeogenic hormones G-6-Pase, PEPCK, and FBPase at the transcriptional level, though the specific molecular mechanisms through which these hormones work, are not completely defined (19, 20) . Animal models have provided some insight. For example, impaired regulation of FBPase in New Zealand obese mice leads to increased hepatic glucose production (21) . Similarly, in transgenic rats that express a noninsulin responsive PEPCK gene, overt diabetes develops by 3 months of age, in association with other components of syndrome X (such as dyslipidemia) (22) .
This study uses an in vivo rat model that similarly develops overt diabetes and dyslipidemia late in life as a result of a deprived intrauterine milieu (3, 8) . The effect of this deprivation was the recent focus of the First World Congress on Fetal Origins of Adult Disease (23) . The prototypical IUGR human endures a perinatal period characterized by hypoglycemia and hypoinsulinemia (24) . During childhood and early adulthood, the IUGR individual is likely to demonstrate insulin resistance, and it is during the latter half of the adult years that clinically overt diabetes and the other components of syndrome X emerge (1) .
Similar to the IUGR human, the juvenile IUGR rat initially develops peripheral insulin resistance; and the adult IUGR rat demonstrates fasting hyperglycemia, hyperinsulinemia, and hypertriglyceridemia (3, 4, 8) . These pathophysiologies are associated with tissue-specific alterations in glucose and fatty acid metabolizing enzyme gene expression and function that persist after the initial insult, including increased hepatic expression of carnitine palmitoyl transferase I (4, 8, 11, 12) . Though regulation of hepatic fatty acid metabolizing gene expression is complex, it is noteworthy that PGC-1 cotranscription factors peroxisome-proliferator-activated receptor-␣ and thyroid receptor contribute to the transcriptional regulation of liver carnitine palmitoyl transferase I (25) (26) (27) .
Interestingly, protein malnutrition of the maternal dam and subsequent IUGR also results in impaired insulin suppression of hepatic glucose production, increased PEPCK activity, and dyslipidemia (5, 28 -30) . Moreover, similar to our findings, the progeny of protein-malnourished dams also demonstrate decreased GK activity, and it has been speculated that this plays a role in the glucose intolerance exhibited by these animals (29, 31) .
At d 0 of life, increased hepatic PGC-1 mRNA and protein levels are associated with higher levels of NRF-1, mTFA, and CoxIV mRNA and corroborate with previous reports directly linking PGC-1 to the expression of these genes, as well as the earlier findings of increased mitochondrial gene expression in IUGR animals (7, 15) .
In summary, IUGR leads to increased hepatic gene expression of PGC-1 during a time period when the affected animal is characterized by peripheral insulin resistance (3). PGC-1 controls hepatic gluconeogenesis and associates with multiple transcriptional coactivators. As a result, our data suggest that hepatic PGC-1 contributes to the early peripheral resistance and the long-term effects of uteroplacental insufficiency in the IUGR rat. Relative quantification of PCR products are then based on value differences between the target and GAPDH control, using the comparative C T method. *, P Ͻ 0.05.
